Latest International Collaboration News

Neurizon Therapeutics has secured FDA clearance for its lead drug candidate NUZ-001 to enter the HEALEY ALS Platform Trial, marking a key regulatory milestone and setting the stage for patient enrollment in early 2026.

Strategic Elements Ltd has marked a key milestone by successfully fabricating Energy Ink™ prototype cells in a commercial setting, while expanding its artificial intelligence ventures and maintaining a robust financial position.

ABx Group Limited reports strong progress in rare earth extraction and clean chemical production, backed by strategic investments and a recent $3 million capital raise.

Arafura Rare Earths has secured a non-binding Letter of Interest from the US Export-Import Bank for up to US$300 million to support its Nolans Project, enhancing the US rare earth supply chain and national security.

Aurora Labs has secured a $450,000 Phase 2 contract from the Australian Department of Defence to prototype a high-thrust, fuel-efficient propulsion system for unmanned aerial systems, building on its innovative 3D metal printing technology.

Cauldron Energy has signed a non-binding MOU with Uzbekistan’s Navoiyuran, a global leader in in-situ recovery uranium mining, to collaborate on advancing the Yanrey Uranium Project in Western Australia. This partnership aims to leverage Navoiyuran’s technical expertise and operational experience to unlock the project’s full potential.

Sparc Technologies reported a narrower FY25 loss alongside progress in green hydrogen and graphene additive projects, supported by government grants and a successful capital raise.

Strategic Elements Ltd has marked significant progress in its Energy Ink™ prototype trials and underground mining technology, maintaining a robust financial footing with $4.21 million cash and no debt.

Sparc Technologies progresses its pioneering green hydrogen pilot plant and graphene-based coatings, backed by a significant government grant and a successful capital raise.

Sparc Technologies has unveiled its first-of-its-kind photocatalytic water splitting pilot plant at the University of Adelaide, marking a key milestone in green hydrogen innovation. Commissioning is set to begin in July 2025, aiming to demonstrate a low-cost, modular alternative to traditional electrolysis.

Audeara Limited has reported record unaudited revenue of $3.64 million for the first 11 months of FY25, marking a 14% increase over FY24 and driven by new product launches and international partnerships.

Noxopharm’s Sofra™ technology has received promising external validation from BioRay Pharmaceutical, confirming its targeted anti-inflammatory potential and broad applicability in autoimmune disease therapies.